SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
|
| Equity [Abstract] | ||
| Number of Shares, Outstanding, Ending balance | 151,170 | |
| Weighted Average Price Per Share, Outstanding, Ending balance | $ 150.00 | |
| Number of Shares, Issued | 151,170 | |
| Weighted Average Price Per Share, Issued | $ 150.00 | |
| Number of Shares, Exercised | (29,841) | |
| Weighted Average Price Per Share, Exercised | $ 26.15 | |
| Number of Shares, Forfeited | ||
| Weighted Average Price Per Share, Forfeited | ||
| Number of Shares, Expired | ||
| Weighted Average Price Per Share, Expired | ||
| Number of Shares, Outstanding, Ending balance | 121,329 | 151,170 |
| Weighted Average Price Per Share, Outstanding, Ending balance | $ 179.63 | $ 150.00 |
| Number of Shares, Exercisable, Ending balance | 76,955 | |
| Weighted Average Price Per Share, Exercisable, Ending balance | $ 283.21 | |
| Weighted average remaining contractual term | 1 year 9 months 7 days | |
| Aggregate intrinsic value | ||
| X | ||||||||||
- Definition Number of equity instruments other than options exercisable, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments issued to participants. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Outstanding Exercisable, Ending. No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Expired. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Issued. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Aggregate intrinsic value. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|